These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16751994)

  • 1. Risk factors for prostatic inflammation extent and infection in benign prostatic hyperplasia.
    Yi FX; Wei Q; Li H; Li X; Shi M; Dong Q; Yang YR
    Asian J Androl; 2006 Sep; 8(5):621-7. PubMed ID: 16751994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden).
    Alexeyev O; Bergh J; Marklund I; Thellenberg-Karlsson C; Wiklund F; Grönberg H; Bergh A; Elgh F
    Cancer Causes Control; 2006 Nov; 17(9):1127-33. PubMed ID: 17006718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?
    Mishra VC; Allen DJ; Nicolaou C; Sharif H; Hudd C; Karim OM; Motiwala HG; Laniado ME
    BJU Int; 2007 Aug; 100(2):327-31. PubMed ID: 17617139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacterial content of the enucleated prostate gland].
    Soler Soler JL; Hidalgo Domínguez MR; Zuluaga Gómez A; Martínez Torres JL; Lardelli Claret P; Liébana Ureña J; Saharour G
    Arch Esp Urol; 1999 Oct; 52(8):823-34. PubMed ID: 10589113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden.
    Chokkalingam AP; Nyrén O; Johansson JE; Gridley G; McLaughlin JK; Adami HO; Hsing AW
    Cancer; 2003 Oct; 98(8):1727-34. PubMed ID: 14534890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Escherichia coli 16S RNA and cytotoxic necrotizing factor 1 gene in benign prostate hyperplasia.
    Bergh J; Marklund I; Thellenberg-Karlsson C; Grönberg H; Elgh F; Alexeyev OA
    Eur Urol; 2007 Feb; 51(2):457-62; discussion 462-3. PubMed ID: 16904256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive factors for conversion of transurethral resection of the prostate to open prostatectomy].
    Liao GD; Shen ZJ; Zhou XL; Chen SW; Chen J; Wang S; Shi SF; Zhang ZG; Cai SL
    Zhonghua Nan Ke Xue; 2007 Jul; 13(7):613-6. PubMed ID: 17725304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerulation observed during transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia is a common finding but no predictor of clinical outcome.
    Furuya R; Masumori N; Furuya S; Oda T; Takahashi S; Takeuchi M
    Urology; 2007 Nov; 70(5):922-6. PubMed ID: 18068448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
    Alemu MH
    Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate.
    Agren A; Kolmert T; Wiman B; Schulman S
    Thromb Res; 2007; 119(6):715-21. PubMed ID: 16905180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some aspects of transurethral resection of large benign prostatic hyperplasia].
    Managadze LG; Khvadagiani GG; Abdushelishvili KO; Managadze GL; Berulava DT
    Georgian Med News; 2007 Feb; (143):53-7. PubMed ID: 17404441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenetic mechanisms of infectious-inflammatory and thrombohemorrhagic complications of transurethral prostatic resection].
    Malyshev AV; Vasil'ev IuV
    Urologiia; 2004; (2):54-8. PubMed ID: 15114757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
    Jeldres C; Isbarn H; Capitanio U; Zini L; Bhojani N; Shariat SF; Cloutier V; Lattouf JB; Duclos A; Jolivet-Tremblay M; Valiquette L; Saad F; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Aug; 182(2):626-32. PubMed ID: 19535100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
    Chalise PR; Agrawal CS
    Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory changes in the obstructed prostate: the correlation between the bacteriological and histological findings].
    Soler Soler JL; Martínez Torres JL; Hidalgo Domínguez Mdel R; Lardelli Claret P; Liébana Ureña J; Zuluaga Gómez A; Saharour G
    Arch Esp Urol; 1999 Sep; 52(7):729-38. PubMed ID: 10540763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.